Merck, Sharp, & Dohme (MSD) and Al-Jishi Corporation have enjoyed a partnership that has spanned over 57 years. As MSD announced its spinoff as Organon & Co., it is with this announcement that Al-Jishi Co. and MSD will both pursue new directions that change the nature of their partnership. Al-Jishi Co. wishes MSD and Organon & Co. success in their new endeavor, and is undergoing changes simultaneously that they are excited to introduce to the market.
We look forward to seeing the new shift towards women’s health that Organon & Co. hopes to pursue. Al-Jishi Co. has recently onboarded an experiential retail division with plans to enhance their medical innovative solutions and beyond over the course of the next 2-3 years.
As both Organon & Co. and Al-Jishi Co. drive efforts into these new avenues, both organizations wish one another success and prosperity that will help revolutionize the pharmaceutical industry and bring innovation to those who need it most: our patients.